These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Characterization of Growth Hormone Resistance in Experimental and Ulcerative Colitis. Soendergaard C; Kvist PH; Thygesen P; Reslow M; Nielsen OH; Kopchick JJ; Holm TL Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28946616 [TBL] [Abstract][Full Text] [Related]
7. Human thioredoxin-1 ameliorates experimental murine colitis in association with suppressed macrophage inhibitory factor production. Tamaki H; Nakamura H; Nishio A; Nakase H; Ueno S; Uza N; Kido M; Inoue S; Mikami S; Asada M; Kiriya K; Kitamura H; Ohashi S; Fukui T; Kawasaki K; Matsuura M; Ishii Y; Okazaki K; Yodoi J; Chiba T Gastroenterology; 2006 Oct; 131(4):1110-21. PubMed ID: 17030181 [TBL] [Abstract][Full Text] [Related]
8. Serum miRNA signature diagnoses and discriminates murine colitis subtypes and predicts ulcerative colitis in humans. Viennois E; Zhao Y; Han MK; Xiao B; Zhang M; Prasad M; Wang L; Merlin D Sci Rep; 2017 May; 7(1):2520. PubMed ID: 28566745 [TBL] [Abstract][Full Text] [Related]
9. Plasma lysozyme and alpha1-acid glycoprotein as an index of disease activity in inflammatory bowel disease. van de Merwe JP; Mol GJ Neth J Med; 1977; 20(6):253-6. PubMed ID: 609362 [No Abstract] [Full Text] [Related]
10. Serum adipokine zinc α2-glycoprotein and lipolysis in cachectic and noncachectic heart failure patients: relationship with neurohormonal and inflammatory biomarkers. Tedeschi S; Pilotti E; Parenti E; Vicini V; Coghi P; Montanari A; Regolisti G; Fiaccadori E; Cabassi A Metabolism; 2012 Jan; 61(1):37-42. PubMed ID: 21696792 [TBL] [Abstract][Full Text] [Related]
11. Thrombospondin peptide ABT-898 inhibits inflammation and angiogenesis in a colitis model. Gutierrez LS; Ling J; Nye D; Papathomas K; Dickinson C World J Gastroenterol; 2015 May; 21(20):6157-66. PubMed ID: 26034351 [TBL] [Abstract][Full Text] [Related]
12. Human CRISP-3 binds serum alpha(1)B-glycoprotein across species. Udby L; Johnsen AH; Borregaard N Biochim Biophys Acta; 2010 Apr; 1800(4):481-5. PubMed ID: 20116414 [TBL] [Abstract][Full Text] [Related]
14. Down-regulation of S100A1 protein in patients with metabolic syndrome and its association with zinc-α2-glycoprotein. Ebrahimi E; Kheirouri S; Alizadeh M Scott Med J; 2017 Aug; 62(3):88-95. PubMed ID: 28825380 [TBL] [Abstract][Full Text] [Related]
16. Serum zinc and taste acuity in Tel-Aviv patients with inflammatory bowel disease. Tiomny E; Horwitz C; Graff E; Rozen P; Gilat T Am J Gastroenterol; 1982 Feb; 77(2):101-4. PubMed ID: 7072676 [TBL] [Abstract][Full Text] [Related]
17. Zinc-α2-glycoprotein as a marker of fat catabolism in humans. Cabassi A; Tedeschi S Curr Opin Clin Nutr Metab Care; 2013 May; 16(3):267-71. PubMed ID: 23448999 [TBL] [Abstract][Full Text] [Related]
18. Determination of serum zinc-alpha-2-glycoprotein in patients with metabolic syndrome by a new ELISA. Stejskal D; Karpísek M; Reutová H; Stejskal P; Kotolová H; Kollár P Clin Biochem; 2008 Mar; 41(4-5):313-6. PubMed ID: 18078816 [TBL] [Abstract][Full Text] [Related]
19. Serum zinc-α2-glycoprotein concentrations in patients with non-alcoholic fatty liver disease. Yilmaz Y; Yonal O; Eren F; Kurt R; Celikel CA; Ozdogan O; Imeryuz N; Kalayci C; Avsar E Clin Chem Lab Med; 2011 Jan; 49(1):93-7. PubMed ID: 21077793 [TBL] [Abstract][Full Text] [Related]